Serological and cellular inflammatory signatures in end‐stage kidney disease and latent tuberculosis
Abstract Objectives Tuberculosis comorbidity with chronic diseases including diabetes, HIV and chronic kidney disease is of rising concern. In particular, latent tuberculosis infection (LTBI) comorbidity with end‐stage kidney disease (ESKD) is associated with up to 52.5‐fold increased risk of TB rea...
Guardado en:
Autores principales: | Milla R McLean, Kathleen M Wragg, Ester Lopez, Sandra A Kiazyk, Terry Blake Ball, Joe Bueti, Stephen J Kent, Jennifer A Juno, Amy W Chung |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/76cfc55d07b34fe8b4af19c8ed672243 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Bone Marrow Hypocellularity in Patients with End-Stage Kidney Disease
por: Chia-Chen Hsieh, et al.
Publicado: (2021) -
Secretory Immunoglobulin a (SigA) Testing in Saliva from End-Stage Patients with Chronic Kidney Disease Undergoing Dialysis Treatment and in Control Healthy Subjects
por: Nenova-Nogalcheva A., et al.
Publicado: (2020) -
Urgent-start peritoneal dialysis for end-stage renal disease patients: literature review and worldwide evidence-based practice
por: Atthaphong Phongphithakchai, et al.
Publicado: (2021) -
Autocatalytic cycle in the pathogenesis of diabetes mellitus: biochemical and pathophysiological aspects of metabolic therapy with natural amino acids on the example of glycine
por: Semen V. Nesterov, et al.
Publicado: (2018) -
Serum metabolomics of end-stage renal disease patients with depression: potential biomarkers for diagnosis
por: Dezhi Yuan, et al.
Publicado: (2021)